Karlo Perica

3.2k total citations · 1 hit paper
29 papers, 2.0k citations indexed

About

Karlo Perica is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Karlo Perica has authored 29 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 19 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Karlo Perica's work include CAR-T cell therapy research (24 papers), Immunotherapy and Immune Responses (13 papers) and Immune Cell Function and Interaction (11 papers). Karlo Perica is often cited by papers focused on CAR-T cell therapy research (24 papers), Immunotherapy and Immune Responses (13 papers) and Immune Cell Function and Interaction (11 papers). Karlo Perica collaborates with scholars based in United States, Germany and Sweden. Karlo Perica's co-authors include Jonathan P. Schneck, Andrew Chow, Jedd D. Wolchok, Christopher A. Klebanoff, Jordan J. Green, Joel Sunshine, Mathias Oelke, Juan Carlos Varela, Joan Glick Bieler and Michael Edidin and has published in prestigious journals such as Nature, Cell and Journal of Clinical Oncology.

In The Last Decade

Karlo Perica

27 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical implications of T cell exhaustion for cancer immunotherapy

2022 559 citations Andrew Chow, Karlo Perica et al. Nature Reviews Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karlo Perica United States	17	1.1k	1.1k	600	513	237	29	2.0k
Marieke F. Fransen Netherlands	28	1.3k 1.1×	1.7k 1.5×	539 0.9×	459 0.9×	176 0.7×	55	2.5k
Kyle C. Roche United States	14	540 0.5×	556 0.5×	550 0.9×	828 1.6×	410 1.7×	20	1.6k
Xiuwen Guan China	18	502 0.4×	585 0.5×	727 1.2×	871 1.7×	475 2.0×	30	1.9k
Laura Maiorino United States	10	587 0.5×	916 0.8×	821 1.4×	1.0k 2.0×	721 3.0×	19	2.4k
Wilson S. Meng United States	24	401 0.4×	822 0.8×	844 1.4×	246 0.5×	334 1.4×	61	1.8k
Yuqing Xie China	14	522 0.5×	603 0.6×	461 0.8×	530 1.0×	187 0.8×	31	1.4k
Lydia Koenig United States	10	1.2k 1.0×	939 0.9×	456 0.8×	185 0.4×	199 0.8×	14	1.9k
Junhua Mai United States	25	534 0.5×	554 0.5×	1.1k 1.8×	595 1.2×	472 2.0×	58	2.1k
Yao Xu United States	17	561 0.5×	1.6k 1.5×	1.0k 1.7×	1.0k 2.0×	386 1.6×	32	2.5k
Jun Ishihara United States	19	523 0.5×	574 0.5×	414 0.7×	299 0.6×	202 0.9×	38	1.4k

Countries citing papers authored by Karlo Perica

Since Specialization

Citations

This map shows the geographic impact of Karlo Perica's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karlo Perica with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karlo Perica more than expected).

Fields of papers citing papers by Karlo Perica

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karlo Perica. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karlo Perica. The network helps show where Karlo Perica may publish in the future.

Co-authorship network of co-authors of Karlo Perica

This figure shows the co-authorship network connecting the top 25 collaborators of Karlo Perica. A scholar is included among the top collaborators of Karlo Perica based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karlo Perica. Karlo Perica is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lopez, Michael, Ivan S. Kotchetkov, Leena Halim, et al.. (2025). pTα enhances mRNA translation and potentiates CAR T cells for solid tumor eradication. Cell. 189(2). 401–417.e21.

Perica, Karlo, Ivan S. Kotchetkov, Jorge Mansilla‐Soto, et al.. (2025). HIV immune evasin Nef enhances allogeneic CAR T cell potency. Nature. 640(8059). 793–801. 8 indexed citations

Martin, Karen E., Quirin Hammer, Karlo Perica, Michel Sadelain, & Karl‐Johan Malmberg. (2024). Engineering immune-evasive allogeneic cellular immunotherapies. Nature reviews. Immunology. 24(9). 680–693. 29 indexed citations

Dobrin, Anton, Yuzhe Shi, Karlo Perica, et al.. (2024). Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies. Nature Cancer. 5(5). 760–773. 11 indexed citations

Hammer, Quirin, Karlo Perica, Rina M. Mbofung, et al.. (2024). Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies. Cell stem cell. 31(9). 1376–1386.e8. 18 indexed citations

Shah, Gunjan L., Karlo Perica, Kinga Hosszu, et al.. (2024). Manufacture of Anti-BCMA CAR T Cell Is Feasible after Salvage Autologous or Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 144(Supplement 1). 4850–4850.

Chung, David J., Sneh Sharma, Susan DeWolf, et al.. (2022). Langerhans dendritic cell vaccine bearing mRNA-encoded tumor antigens induces antimyeloma immunity after autotransplant. Blood Advances. 6(5). 1547–1558. 30 indexed citations

Chow, Andrew, Karlo Perica, Christopher A. Klebanoff, & Jedd D. Wolchok. (2022). Clinical implications of T cell exhaustion for cancer immunotherapy. Nature Reviews Clinical Oncology. 19(12). 775–790. 559 indexed citations breakdown →

Hammer, Quirin, Karlo Perica, Rina M. Mbofung, et al.. (2022). Combined Genetic Ablation of CD54 and CD58 in CAR Engineered Cytotoxic Lymphocytes Effectively Averts Allogeneic Immune Cell Rejection. Blood. 140(Supplement 1). 1165–1166. 5 indexed citations

10.

Lee, Jung Seok, Patrick Han, Sean Bickerton, et al.. (2021). Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin. Nature Biomedical Engineering. 5(9). 983–997. 49 indexed citations

11.

Perica, Karlo, Jessica Flynn, Kevin J. Curran, et al.. (2021). Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia. Leukemia. 35(11). 3268–3271. 26 indexed citations

12.

Perica, Karlo, Kevin J. Curran, Renier J. Brentjens, & Sergio Giralt. (2018). Building a CAR Garage: Preparing for the Delivery of Commercial CAR T Cell Products at Memorial Sloan Kettering Cancer Center. Biology of Blood and Marrow Transplantation. 24(6). 1135–1141. 57 indexed citations

13.

Perica, Karlo, Juan Carlos Varela, Mathias Oelke, & Jonathan P. Schneck. (2015). Adoptive T Cell Immunotherapy For Cancer. SHILAP Revista de lepidopterología. 6(1). e0004–e0004. 168 indexed citations

14.

Perica, Karlo, Ang A. Tu, Anne Richter, et al.. (2014). Magnetic Field-Induced T Cell Receptor Clustering by Nanoparticles Enhances T Cell Activation and Stimulates Antitumor Activity. ACS Nano. 8(3). 2252–2260. 201 indexed citations

15.

Perica, Karlo, Alyssa K. Kosmides, & Jonathan P. Schneck. (2014). Linking form to function: Biophysical aspects of artificial antigen presenting cell design. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853(4). 781–790. 42 indexed citations

16.

Perica, Karlo, Joan Glick Bieler, Christian Schuetz, et al.. (2014). Enrichment and expansion with nanoscale artificial antigen presenting cells for T cell adoptive immunotherapy. Journal for ImmunoTherapy of Cancer. 2(S3). 2 indexed citations

17.

Schütz, Christian, et al.. (2014). Antigen-specific T cell redirectors (ATR) for antigen-specific redirection of T cells to tumors. Journal for ImmunoTherapy of Cancer. 2(S3). 1 indexed citations

18.

Sunshine, Joel, Karlo Perica, Jonathan P. Schneck, & Jordan J. Green. (2013). Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells. Biomaterials. 35(1). 269–277. 213 indexed citations

19.

Perica, Karlo, Joan Glick Bieler, Michael Edidin, & Jonathan P. Schneck. (2012). Modulation of MHC Binding by Lateral Association of TCR and Coreceptor. Biophysical Journal. 103(9). 1890–1898. 8 indexed citations

20.

Samstein, Robert, et al.. (2007). The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles. Biomaterials. 29(6). 703–708. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact